Opinion: Washington on the Brink of Meaningful PBM Reform

As pharmacy benefit managers (PBMs) face increasing scrutiny from policymakers, Washington is moving toward significant regulatory reforms. PBMs, which manage prescription drug benefits for millions of Americans, are being held to fiduciary standards—meaning they must act in patients' best interests rather than prioritizing corporate profits. This shift represents a critical moment for healthcare reform that could improve medication access and affordability for patients managing chronic conditions. The proposed reforms aim to increase transparency and reduce barriers to necessary prescriptions, potentially benefiting those relying on medications for conditions like diabetes, heart disease, and arthritis.